Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
BK virus infections are very frequent during months following a kidney transplantation: a viral reactivation is observed for almost 50% of patients during first year. This reactivation leads to a viremia for 10 to 15% of patient during this same period. The most frequent complication is interstitial nephritis for 2 to 8% of patients (27 patients representing 2.7% during 6 years in Nantes).
An intensive et persisting viral replication, assessed by detection of high blood viral load, could evolved to a viral nephropathy which lead to a very pejorative functional issue for the graft.
Biological follow-up of these infections lay on the measures of viral load. Their positivity must alert the physician and lead him to modulate immunosuppressive treatment.
Actually, there is no real consensus about the modalities of pharmacological immunosuppression decrease (decrease dose or change of molecule).
Specific lymphocytic anti-BKv evaluated on several cohorts of patients permit to prove:
New prospective and longitudinal data comparing the immune cellular response (systematic and early) after graft between patients controlling or not BKv infection are necessary to improve the comprehension of illness natural history.
The investigators propose to enlarge the investigation of anti-BKv immune cellular response to other functions than IFNg synthesis in the aim of detecting the eventual role of polyfunctional lymphocytes for infection control. Furthermore, the investigators propose to identify better diagnostic and prognostic makers.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| kidney-transplanted patients |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| biological parameters | Other | blood sample at M1, M2, M3; M4; M5, M6, M7, M8 and M9 after kidney transplantation |
|
| Measure | Description | Time Frame |
|---|---|---|
| Comparison of the level of response between patient with a "non-controlled infection" and patients for who the blood viral load is under 103 copBKv/ml. | Analyse the role of T-lymphocytes response in the control of BKv infection | at 1month, 2months, 3months, 4, 5, 6, 7, 8 and 9 months after kidney transplantation |
| Measure | Description | Time Frame |
|---|---|---|
| Analyse of the other causes that could influence the occurence of a viremia higher than 103 copBKv/ml | Other causes for abnormal viremia | at 1month, 2months, 3months, 4, 5, 6, 7, 8 and 9 months after kidney transplantation |
| Measurement of histological consequences of a BKv non-controlled infection during the first year post-graft |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Kidney-transplanted person
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Nantes' Univeristy hospital | Nantes | 44000 | France |
Not provided
Not provided
Not provided
Not provided
Determine the frequence of occurence of nephropathy due to BKv for the population with a non-controlled infection |
| at 12 months after kidney transplantation |
| Measurement of increase of immune response due to modifications of immunosuppressive treatment for patient with a non-controlled infection | Comparision between the level of immune response and the time when the first viremia is higher than 103 copBKv/ml and 1, 3 et 6 months after modification of immunosuppressive treatment. | at 1, 3 et 6 months after modification of immunosuppressive treatment |